Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Strides Shasun gets USFDA nod for pain relieving drug

"The product received approval in 15 months under the new GDUFA regime," Strides Shasun said in a regulatory filing today.

June 12, 2017 / 11:41 AM IST
Granules India Ltd.

Granules India Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Strides Shasun has received the US health regulator's nod for Amantadine Hydrochloride tablets, used in the treatment of Parkinson's disease and Shingles to reduce pain.

"The product received approval in 15 months under the new GDUFA regime," Strides Shasun said in a regulatory filing today.

"Strides Shasun... has received approval from the USFDA for Amantadine Hydrochloride tablets 100 mg," it said.

According to IMS data, the US market for this product is approximately USD 22 million (around Rs 141 crore) with two generic players. The product will be launched immediately.

Shares of the company were trading 1.93 per cent lower at Rs 924.10 apiece on BSE.

first published: Jun 12, 2017 11:23 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347